Microdose clinical trial for prediction of interindividual variability of PK and PD in patients administered with atorvastatin, pravastatin, rosuvastitine or telmisartan

Microdose clinical trial for prediction of interindividual variability of PK and PD in patients administered with atorvastatin, pravastatin, rosuvastitine or telmisartan - Microdose clinical trial for prediction of interindividual variability of PK and PD in patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003104

Enrollment

160

Registered

2010-01-27

Start date

2010-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension or hyperlipidemia

Interventions

administration with lesser dose (100&amp

micro

g or one hundredth of therapeutic dose) administration with therapeutics dose

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient is; 1) able to understand and willing to sign the informed consent. 2)diagnosed as hypertension or hyperlipidemia

Exclusion criteria

Exclusion criteria: Patients wiht any conditions that the investigators judged unsuitable for the study.

Design outcomes

Primary

Measure	Time frame
PK parameters and genetic variations in patients compared with known data from healthy volunteers	—

Countries

Japan

Contacts

Public ContactInano Akihiro

APDD APDD

inano-heart@bpost.plala.or.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026